MAPT and tauopathy: In this context, whole genome methylation analysis in individuals with dementia has shown that the H1 MAPT haplotype as a risk factor for tauopathy may depend on methylation changes in the genetic locus encoding tau protein, suggesting that epigenetic modifications might affect genetic predisposition to PSP [136]).